Presentation TCT 2016 Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Second Generation Durable Polymer DES are the Gold Standard and Remain Superior to Bioabsorbable Polymer DES! Presenter: Stephan Windecker, Tullio Palmerini October 31, 2016
Presentation TCT 2016 Double-edged Sealing Embolic Protection Device (Transverse) Presenter: Eric Goslau October 31, 2016
Presentation TCT 2016 Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES! Presenter: Stephan Windecker, Michael Joner October 31, 2016
Presentation TCT 2016 Featured Lecture: Overview of Currently Available and Under Development Bioabsorbable Polymer-based DES Programs. Are There Meaningful Differences? Presenter: Stephan Windecker, Julinda Mehilli October 31, 2016
Presentation TCT 2016 Potential Advantages and Pitfalls of Bioabsorbable Polymers Presenter: Stephan Windecker, Renu Virmani October 31, 2016
Presentation TCT 2016 The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari October 31, 2016
Presentation TCT 2016 Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber October 31, 2016
Presentation TCT 2016 Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik October 31, 2016
Presentation TCT 2016 Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner October 31, 2016
Presentation TCT 2016 TCT 1129: Safety and Efficacy of Percutaneous Implantable Right Ventricular Assist Device for Management of Right Ventricular Failure Secondary to Acute Inferior Myocardial Infarction Presenter: Maurice Buchbinder, Marco A. Costa, Abhishek Sawant October 30, 2016
Presentation TCT 2016 Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results Presenter: Ajay J. Kirtane, Bryan Williams, Atul Pathak October 30, 2016
Presentation TCT 2016 Appropriate Use Criteria of LAA Closure Devices: PMDAs View Presenter: Mitchell W. Krucoff, Shigeru Saito, Sara Takahashi October 30, 2016
Presentation TCT 2016 Appropriate Use Criteria of LAA Closure Devices: FDAs View Presenter: Mitchell W. Krucoff, Shigeru Saito, Rachel Neubrander October 30, 2016
Presentation TCT 2016 Appropriate Use Criteria of LAA Closure Devices: US Industry View Presenter: Mitchell W. Krucoff, Shigeru Saito, Kenneth Stein, MD October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Kona WAVE IV Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri October 30, 2016
Presentation TCT 2016 Lessons Learned from Early FIH/EFS Trials: Transcatheter Pulmonary Valve Replacement Presenter: John G. Webb, Ajit Yoganathan, John P. Cheatham October 30, 2016
Presentation TCT 2016 Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure Device Candidates in Both Countries Presenter: Mitchell W. Krucoff, Shigeru Saito, Christopher B. Granger October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White October 30, 2016
Presentation TCT 2016 Lessons Learned from Early FIH/EFS Trials: Tricuspid Valve Repair Technologies Presenter: John G. Webb, Ajit Yoganathan, Scott Lim October 30, 2016